GlassScriptPhysician profile
George Sanchez
NPI 1932859949
$2,077.79
in general payments reported to CMS, 2019-2025
7 companies · $855 in 2025
The $855 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $360 · 2024: $863 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,077.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,390.53 | 2023-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Abbvie INC. | $222.84 | 2023-2024 | Xen Glaucoma Treatment System |
| Sight Sciences, INC. | $148.20 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Neurotech Pharmaceuticals, INC. | $139.10 | 2025 | |
| Dompe US, INC. | $121.82 | 2025 | Oxervate |
| Genentech USA, INC. | $28.96 | 2025 | Vabysmo |
| Dutch Ophthalmic, USA | $26.34 | 2025 | Tissueblue, Eva, Combined Machine |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.